Scientific Articles
Oct 17, 2025
AL Amyloidosis: A Real-World Experience with CAR-T Cell TherapyMelinda SY Tan1 , Rahma Warsame1 , Ricardo Parrondo2 , Eli Muchtar1 , Taxiarchis Kourelis1 , Francis…
Oct 16, 2025
Key PointsElranatamab elicits deep and rapid heme responses in patients with relapsed AL amyloidosis, including minimal residual disease negativity.No new adverse…
Sep 29, 2025
Amyloid light-chain (AL) amyloidosis is the most prevalent type of diagnosed systemic amyloidosis in Western countries, characterized by the deposition of misfolded…
Jun 02, 2025
AbstractBackground and AimsConcomitant aortic stenosis (AS) and transthyretin-associated cardiac amyloidosis (ATTR-CA) is an increasingly recognized cause of…
May 27, 2025
AbstractThe appearance of new treatments for the different forms of ATTR has highlighted the importance of early diagnosis, since most of these treatments are…
May 13, 2025
AbstractOver 150 transthyretin (TTR) mutations have been identified in hereditary transthyretin (ATTRv) amyloidosis, and new TTR variants have recently emerged.…
May 13, 2025
Hereditary amyloid transthyretin variant (ATTRv) amyloidosis is a rare, life-threatening disease, characterized by the deposition of aggregated transthyretin (TTR)…
May 05, 2025
AbstractTransthyretin amyloid cardiomyopathy (ATTR-CM) is an infiltrative cardiomyopathy that results from myocardial deposition of misfolded transthyretin (TTR)…
Apr 29, 2025
BackgroundThe diversity of disease phenotypes associated with transthyretin (ATTR) amyloidosis poses challenges for measurement of health outcomes. The…
Apr 28, 2025
AbstractObjectiveOur study aimed to report the clinical features and epidemiological characteristics of hereditary transthyretin amyloidosis-polyneuropathy(ATTRv-PN…